Department of Radiation Oncology, King Fahad Specialist Hospital, Amer Bin Thabet Street Al Dammam 15221, Saudi Arabia
Research Article
Progesterone Receptor Expression Level Within Immunohistochemically Determined Early Stage Node Negative Luminal-B Breast Cancer: Forecasting Implication, Outcome and Concordance to Oncotype-DX Recurrence Scores
Author(s): Hala Ahmed Zaghloul*, Lulwah Abduljabbar, Karim Abdel Halim and Miral Mashhour
Purpose: To depict Progesterone Receptor (PR) expression exerted modulations on Oncotype-DX Recurrence Scores (RS) in immunehistochemically
determined node-negative luminal-B-like breast cancers with Ki67 between ≥ 14% and <30% alongside their potentials in
forecasting the outcome.
Methods: The impact of PR variations on Oncotype-Dx RS alongside their implications to the different prognosticators, including adjuvant
chemotherapy, local and distant Recurrence-Free Survival (RFS) were scrutinized. Additionally, the concordance of the Hormone Receptor (HR)
quantifying approaches devising immune staining and Reverse Transcriptase-Polymerase Reaction (RT-PCR) were statistically particularized.
Results: We selected 250 surgically treated node-negative Luminal-B1 (Ki67 ≥ 14%-<20%) and Luminal-B2(Ki.. Read More»
DOI:
10.37421/1948-5956.2024.16.606
Cancer Science & Therapy received 5332 citations as per Google Scholar report